Aster Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Buy
29,970
+28,729
+2,315% +$2.32M 0.5% 39
2026
Q1
$112K Buy
+1,241
New +$119K 0.04% 313
2025
Q1
Sell
-1,094
Closed -$87.4K 1513
2024
Q4
$87.4K Sell
1,094
-45,122
-98% -$3.91M 0.03% 405
2024
Q3
$4.16M Buy
+46,216
New +$3.89M 0.9% 22

Other funds holding MDT

Aster Capital Management's MDT Position: Q2 2026 in Review

Aster Capital Management increased its Medtronic (MDT) stake by 2,315% in Q2 2026, buying an estimated $2.32M and bringing the position to 29,970 shares worth $2.34M. The position accounts for 0.5% of the portfolio, ranked #39.

Aster Capital Management first reported a position in MDT in Q3 2024 and has held it in 4 quarters since. The position peaked at $4.16M in Q3 2024. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Aster Capital Management held 29,970 shares of Medtronic worth $2.34M as of Q2 2026.
  • Aster Capital Management bought 28,729 Medtronic shares in Q2 2026, an estimated $2.32M.
  • Medtronic made up 0.5% of Aster Capital Management's portfolio in Q2 2026, its #39 holding.
  • Aster Capital Management first reported a position in Medtronic in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Medtronic position peaked at $4.16M in Q3 2024.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.